The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $400,132 in first-year total cost, median $78,250.
Most frequent study sections
- Special Emphasis Panel[ZTR1 RD-3 (01)]3
- Special Emphasis Panel[ZTR1 RD-2 (01)]1
- Special Emphasis Panel[ZTR1 RD-7 (02)]1
Most frequent institutions
- BOSTON COLLEGE1
- CINCINNATI CHILDRENS HOSP MED CTR1
- LURIE CHILDREN'S HOSPITAL OF CHICAGO1
- MEDICAL UNIVERSITY OF SOUTH CAROLINA1
- RESEARCH TRIANGLE INSTITUTE1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | PHOX2B Congenital Central Hypoventilation Syndrome (CCHS) Physiologic Signatures in Readiness for Future Clinical Trials1R03TR003869-01A1 | WEESE-MAYER, DEBRA ELLYN | LURIE CHILDREN'S HOSPITAL OF CHICAGO, IL | $77,500 | ZTR1 |
| 2021 | Determining minimal clinically important differences for neurodevelopmental outcome measures in Angelman syndrome1R03HD105507-01 | SADHWANI, ANJALIWHEELER, ANNE CAROLINE | RESEARCH TRIANGLE INSTITUTE, NC | $90,132 | ZTR1 |
| 2021 | Urinary Lipidomic profile in FSGS: A novel biomarker1R03TR003916-01A1 | ERKAN, ELIF | CINCINNATI CHILDRENS HOSP MED CTR, OH | $79,500 | ZTR1 |
| 2020 | Identifying predictors of reversible congenital hypogonadotropic hypogonadism1R03TR003533-01 | DWYER, ANDREW ALOIS | BOSTON COLLEGE, MA | $78,250 | ZTR1 |
| 2019 | Clinical Assessment of a novel non-invasive assay for diagnosing recurrent focal and segmental glomerulosclerosis1R03TR003038-01 | NIHALANI, DEEPAK | MEDICAL UNIVERSITY OF SOUTH CAROLINA, SC | $74,750 | ZTR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.